Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study
- Submitting institution
-
The University of Manchester
- Unit of assessment
- 4 - Psychology, Psychiatry and Neuroscience
- Output identifier
- 83251469
- Type
- D - Journal article
- DOI
-
10.1016/S2215-0366(18)30252-9
- Title of journal
- The Lancet Psychiatry
- Article number
- -
- First page
- 797
- Volume
- 5
- Issue
- 10
- ISSN
- 2215-0366
- Open access status
- Not compliant
- Month of publication
- August
- Year of publication
- 2018
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
61
- Research group(s)
-
B - Psychology and Mental Health
- Citation count
- 51
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- I contributed to the conception and design of the study; organisation of the conduct of the study and carrying out the study. I helped draft the output.
- Non-English
- No
- English abstract
- -
